Abstract
Purpose To study the changes in the corneal epithelium and corneal sensitivity of healthy subjects after the topical administration of non-steroidal anti-inflammatory drugs (NSAIDs; diclofenac, indomethacin, flurbiprofen and ketorolac) frequently used in ocular therapy.
Methods A double-masked parallel clinical study was undertaken on 90 subjects (45 men, 45 women; Caucasian; age 21–46 years, mean SD 27.1 5 years). The subjects were divided into six groups: group 1 was treated with placebo, group 2 with 0.1% diclofenac, group 3 with 0.1% indomethacin, group 4 with 0.03% flurbiprofen, group 5 with 0.5% ketorolac and group 6 with 0.4% oxybuprocaine. One eye was randomly treated with the study drug and the fellow eye was treated with placebo. The medications were instilled four times, at 5 min intervals. Assessment of the corneal epithelium was carried out by vital fluorescein stain before instillation and 5, 15, 30 and 60 min after instillation of the last drop. Subjective burning sensation was assessed by asking participants to rate burning on a scale from 0 (none) to 3 (severe). After 1 week, assessment of corneal sensitivity was carried out by the Cochet-Bonnet method, repeating the above scheme of instillation and measurement times.
Results None of the study drugs, with the exception of oxybuprocaine, produced evident epithelial damage. All the drugs caused a mean burning sensation greater than the placebo. The diclofenac-treated group showed a statistically significant decrease in corneal sensitivity (p 0.001) at the measurement carried out 15 min after instillation of the last drop and lasting up to the end of the study, when the corneal anaesthesia was similar to that induced by the topical anaesthetic treatment. No significant changes were
demonstrated for the other NSAIDs when compared either with the placebo-treated eyes or with the fellow eyes.
Conclusions Despite a similar mechanism of action and analgesic activity to the other NSAIDs tested, diclofenac was able to induce a reduction in corneal sensitivity. More studies are needed to determine the mechanism of action responsible for this effect.
Similar content being viewed by others
Article PDF
References
Flach AJ . Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992;36:259–84.
Gwon A, Vaughan ER, Cheetham JK, De Gryse . Ocufen (Flurbiprofen) in the treatment of ocular pain after radial keratotomy. CLAO J 1994;20:131–8.
Arshinoff S, D'Addario D, Sadler C, Bilotta R, Johnson TM . Use of topical non-steroidal antiinflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg 1994;20 (Suppl):216–22.
Millodot M . The influence of age on the sensitivity of the cornea. Invest Ophthalmol Vis Sci 1977;16:240–2.
Riss B, Binder S, Riss P, Kemeter P . Corneal sensitivity during the menstrual cycle. Br J Ophthalmol 1982;66:123–6.
Kodama T, Hayasaka S, Setogawa T . Immunofluorescent staining and corneal sensitivity in patients suspected of having herpes simplex keratitis. Am J Ophthalmol 1992;113:187–9.
McNamara NA, Brand RJ, PoIse KA, Bourne WM . Corneal function during normal and high serum glucose levels in dibetes. Invest Ophthalmol Vis Sci 1998;39:3–17.
Martin XY, Sapran AB . Corneal hypoesthesia. Surv Ophthalmol 1988;33:28–40.
Koenig SB, Berkowitz RA, Beuerman RW, McDonald MB . Corneal sensitivity after epikeratophakia. Ophthalmology 1983;90:1213–8.
Shivitz lA, Arrowsmith PN . Corneal sensitivity after radial keratotomy. Ophthalmology 1988;95:87–32.
Campos M, Hertzog L, Garbus JJ, McDonnell PJ . Corneal sensitivity after photorefractive keratectomy. Am J OphthalmoI 1992;114:51–4.
Loya N, Bassage S, Vyas S, del Cerro M, Park SB, Aquavella JV . Topical diclofenac following excimer laser: effect on corneal sensitivity and wound healing in rabbits. J Refract Corneal Surg 1994;10:423–7.
Szerenyi K, Sorken K, Garbus J, Lee M, McDonnell PJ . Decrease in normal human corneal sensitivity with topical diclofenac sodium. Am J Ophthalmol 1994;118:312–5.
Zaidman GW . Diclofenac and its effect on corneal sensation. Arch Ophthalmol 1995;113:262.
Aragona P, Fragalà I, Oteri FC, Battaglia F, Ferreri G . Effect of the topical administration of diclofenac sodium and indomethacin on corneal sensitivity in normal subjects. Vision Res 1995;35 (Suppl):S146.
Insel PA . Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman Gilman A, Rail TVV, Nies AS, Taylor P, editors. Goodman and Gilman's The pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990:638–81.
Buckley MM, Brogden RN . Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990;39:86–109.
Lemp MM . Report of the National Eye Institute/Industry workshop on clinical trials in dry eye. CLAO J 1995;21:221–32.
Cochet P, Bonnet R . L'esthesie cornéenne. Clin Ophthalmol 1960;4:3–27.
Laitinen J, Nuutinen L, Kiiskila EL, Freudental Y, Ranta P, et al. Comparison of intravenous diclofenac, indomethacin and oxycodone as post-operative analgesics in patients undergoing knee surgery. Eur J Anaesth 1992;9:29–34.
Bellamy N, Bensen WG, Ford PM, Huang SH, Lang JY . Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis. Clin Invest Med 1992;15:427–33.
Toscani F, Piva L, Corli O, Gallucci M, Speranza R, Tamburini M, De Conno F, Ventafridda V . Ketorolac versus diclofenac sodium in cancer pain. Arzneimittelforschung 1994;44:550–4.
Todd PA, Sorkin EM . Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1988;35:244–85.
Martini A, Bondiolotti GP, Sarcerdote P, Pierro L, Picotto GB, et al. Diclofenac increases beta-endorphins plasma concentrations. J Int Med Res 1984;12:92–5.
Rainsford KD . The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side-effects. In: Rainsford KD, editor. Azapropazone: 20 years of clinical use. Lancaster: Kluwer Academic, 1989:31–52.
Chen X, Gallar J, Belmonte C . Reduction by anti-inflammatory drugs of the response of corneal sensory nerve fibres to chemical irritation. Invest Ophthalmol Vis Sci 197;38:1944–53.
McCormack K, Brune K . Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: a survey of their analgesics efficacy. Drugs 1991;41:533–47.
Ellis PP, Pfoff DS, Bloedow DC, Riegel M . Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application. J Ocul Pharmacol 1994;10:677–82.
Frangouli A, Shah S, Chatterjee A, Morgan PB, Kinsey J . Efficacy of topical nonsteroidal drops as pain relief after excimer laser photorefractive keratectomy. J Refract Surg 1998;14(2 Suppl):S207–8.
Solomon KD, Turkalj JW, Whiteside SB, Stewart JA, Apple DJ . Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol 1997;115:1119–22.
Shimazaki J, Saito H, Yang HY, Toda I, Fujishima H, Tsubota K . Persistent epithelial defects following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea 1995;16:623–7.
Assouline M, Renard G, Arne JL, David T, Lasmolles C, Malecaze F, Pouliquen YJ . Prospective randomized trial of topical soluble 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy. Ophthalmic Surg Lasers 1998;29:365–74.
Sun R, Gimbel HV . Effects of topical ketorolac and diclofenac on normal corneal sensation. J Refract Surg 1997;13:158–61.
Seitz B, Sorken K, LaBree LD, Garbus JJ, McDonnell PJ . Corneal sensitivity and burning sensation. Arch Ophthalmol 1996;114:921–4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aragona, P., Tripodi, G., Spinella, R. et al. The effects of the topical administration of non-steroidal anti-inflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects. Eye 14, 206–210 (2000). https://doi.org/10.1038/eye.2000.55
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.55
Keywords
This article is cited by
-
Wundheilung der Kornea – Pharmakologische Therapie
Die Ophthalmologie (2024)
-
Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets
Drugs (2022)
-
Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
Journal of Inflammation (2017)
-
Management of Dry Eye in Sjögren’s Syndrome
Current Treatment Options in Rheumatology (2015)
-
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients
Eye (2005)